文献速递肝病

西班牙裔原发性胆汁性胆管炎患者碱性磷酸酶正常化率较低

Alkaline Phosphatase Normalization Occurs Less Frequently in Hispanic Patients With Primary Biliary Cholangitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-01-29

该回顾性队列研究纳入东洛杉矶拉丁裔PBC队列427例患者,评估UDCA治疗后完全生化缓解(CBR)的种族差异。西班牙裔患者1年CBR率为13.8%,非西班牙裔白人为41.4%,校正协变量后西班牙裔CBR的比值比为0.31(95%CI 0.10-0.99;

要点

  • 西班牙裔PBC患者UDCA治疗后1年CBR率显著低于非西班牙裔白人。
  • 基线ALP水平在西班牙裔与非西班牙裔白人之间无显著差异。
  • 五移植无生存率及失代偿事件在种族间无显著差异。

核心结论

  • 西班牙裔及更广泛非白人PBC患者达到CBR的可能性显著低于非西班牙裔白人。

研究设计与样本

  • 回顾性研究,纳入南加州大学医学中心2006-2022年东洛杉矶拉丁裔PBC队列427例患者。

主要发现

  • 1年CBR率非西班牙裔白人为41.4%,西班牙裔为13.8%,非白人为13.2%。
  • 五移植无生存率及失代偿事件在种族和民族间无显著差异。

临床怎么用

  • 应关注西班牙裔等弱势人群PBC治疗应答障碍,以ALP正常化为治疗目标时需针对性干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Alkaline phosphatase (ALP) normalization is increasingly recognized as the optimal treatment target in primary biliary cholangitis (PBC). We evaluated racial and ethnic differences in complete biochemical remission (CBR) to ursodeoxycholic acid (UDCA), with a focus on Hispanic populations. METHODS: We conducted a retrospective study of the East Los Angeles Latinx PBC cohort, which includes predominantly Hispanic patients at the University of Southern California Medical Centers (2006-2022). PBC was defined using the American Association of Liver Disease criteria. Five-year transplant-free survival and decompensation event were estimated using Kaplan-Meier method. CBR, defined as ALP ≤1 × the upper limit of normal at 1 year after UDCA initiation, was assessed using multivariable logistic regression. RESULTS: Of 427 patients, 96 (22.5%) were non-Hispanic White (NHW) and 331 (77.5%) were non-White, including 282 Hispanic patients. Five-year transplant-free survival and decompensation event did not differ significantly by race and ethnicity. Among UDCA-naive patients (N = 158), median baseline ALP levels were similar between NHW (231 U/L; interquartile range [IQR], 128-565), Hispanic (285 U/L; IQR, 193-464; P = .21), and non-White patients (275 U/L; IQR, 180-443; P = .25). At 1 year, CBR rates were 41.4% in NHW, 13.8% in Hispanic, and 13.2% in non-White patients, corresponding to 69% lower odds of CBR in Hispanic patients (odds ratio, 0.31; 95% confidence interval, 0.10-0.99; P = .048) and 77% lower odds in non-White patients (odds ratio, 0.23; 95% confidence interval, 0.07-0.82; P = .01) after adjusting for covariates. CONCLUSIONS: Hispanic patients with PBC, and more broadly non-White patients, were significantly less likely than NHW patients to achieve CBR despite comparable baseline ALP levels. As ALP normalization becomes the preferred therapeutic target, addressing barriers to treatment response in underserved populations is essential.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Yoon P, Shen A, Chen M, et al. Alkaline Phosphatase Normalization Occurs Less Frequently in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2026. PMID: 41620193. doi:10.1016/j.cgh.2026.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。